share_log

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co.以買入評級啓動對OKYO Pharma的報道,宣佈目標股價爲4美元
Benzinga ·  2023/11/02 07:07

HC Wainwright & Co. analyst Yi Chen initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $4.

HC Wainwright & Co. 分析師陳毅以買入評級開始對OKYO Pharma(納斯達克股票代碼:OKYO)進行報道,並宣佈目標股價爲4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論